export default function DSIPOverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        DSIP &mdash; Delta Sleep-Inducing Peptide &mdash; was isolated from rabbit cerebral blood during electrically-induced sleep in 1977, and its name has been writing checks its evidence can&rsquo;t fully cash ever since. The dramatic sleep-induction claim has not reliably replicated in humans. What does have more consistent support is HPA axis modulation &mdash; meaning it may help normalize how your body responds to stress, rather than knocking you out. Research peaked in the 1980s&ndash;90s and largely stalled. No active clinical development exists. Community interest has revived it in sleep and recovery contexts.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Sleep-Struggling Person &mdash; Desperate for something that actually works</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I&rsquo;ve tried melatonin, magnesium, everything &mdash; my sleep is still shallow and I wake up tired. Someone mentioned DSIP and it sounds like it goes deeper than supplements. Is this real?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>It&rsquo;s named after exactly what they need &mdash; delta sleep induction</strong><br />Delta sleep is the deep, restorative stage most adults don&rsquo;t get enough of. The name &ldquo;Delta Sleep-Inducing Peptide&rdquo; sounds like a direct solution to the problem. And the original 1977 research did show effects on slow-wave sleep in rabbits, which is why the community framing resonates.</li>
          <li><strong>Some early human studies showed positive sleep architecture effects</strong><br />Small human studies from the 1980s and 1990s &mdash; mostly European &mdash; did show some positive effects on sleep architecture in insomnia and narcolepsy patients. These are real studies with real findings, even if the sample sizes were very small and the methodology varied.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The &ldquo;delta sleep-inducing&rdquo; name was given based on one experimental rabbit context nearly 50 years ago. Human replication of that original effect has been inconsistent &mdash; some studies showed benefit, others showed nothing. There are no modern RCTs. Community reports of DSIP&rsquo;s sleep effects range from dramatic to completely absent. If you have a diagnosed sleep disorder, melatonin and CBT-I have vastly more evidence and should come first. DSIP is an investigational compound with stalled research momentum. Net: this might offer something, but it&rsquo;s a fringe tool, not a proven sleep solution.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; Sleep quality as a recovery tool</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;My training load is high and I know sleep is where adaptation happens. I&rsquo;m looking at every tool that might improve sleep depth and next-day recovery &mdash; where does DSIP actually fit in that context?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Recovery-focused athletes take slow-wave sleep very seriously</strong><br />Growth hormone secretion peaks during deep sleep, and tissue repair is strongly linked to sleep quality. Any compound that might increase slow-wave sleep time would be genuinely interesting to an athlete managing high training loads. The DSIP framing hits this directly.</li>
          <li><strong>The stress-axis angle may be relevant for overtraining states</strong><br />The more consistent data around DSIP involves normalizing HPA axis responses &mdash; lowering elevated cortisol and ACTH. For athletes in high-load training blocks where cortisol chronically runs high, this is an interesting angle independent of the direct sleep question.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">Whether subcutaneous injection of DSIP &mdash; a 9-amino-acid peptide &mdash; actually reaches the brain and produces the CNS effects seen in the original experiments is not established pharmacokinetically. The half-life of circulating DSIP is short. The HPA normalization effects may be real but they&rsquo;re characterized in small, old studies, not in athletic populations. If sleep quality is your goal, sleep hygiene optimization and CBT-I are evidence-based first moves. DSIP is at best an investigational add-on after the basics are covered. Net: interesting theoretical fit for the recovery-focused athlete, but the evidence doesn&rsquo;t match the intuitive appeal.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; Sleep architecture optimization, neuropeptide curiosity</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I track sleep stages with a wearable and I&rsquo;m interested in DSIP as an HPA modulator more than a blunt sleep drug. What does the actual mechanistic picture look like, and where does the evidence genuinely run out?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The HPA normalization mechanism is genuinely interesting</strong><br />DSIP appears to modulate ACTH and cortisol responses in stressed states &mdash; a stress-axis normalization effect that is more consistent across studies than the direct sleep induction claim. For a biohacker thinking about chronically elevated cortisol from work stress, training load, or poor sleep, this is a mechanistically distinct intervention from sedatives or melatonin.</li>
          <li><strong>The opioid withdrawal data is the most controlled human evidence</strong><br />Small controlled European studies from the 1980s and 1990s found DSIP reduced opioid withdrawal symptoms with reasonable consistency across trials. This is the best-controlled human evidence DSIP has &mdash; and it suggests real biological activity even if the mechanism isn&rsquo;t fully understood.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">No dedicated DSIP receptor has been identified in 45+ years of research. That&rsquo;s a meaningful scientific red flag &mdash; most neuropeptides with genuine biological effects have characterized receptors with known binding kinetics. The research trajectory is not &ldquo;exciting new compound still under investigation&rdquo; &mdash; it&rsquo;s &ldquo;1977 isolate whose research momentum stalled.&rdquo; There is no active drug development pipeline, which reflects scientific skepticism more than regulatory obstacles. Community protocols for dosing DSIP are essentially folklore &mdash; there are no modern dose-finding studies. Net: mechanistically curious, real biological activity suggested by the opioid withdrawal data, but the receptor gap and stalled pipeline make this a low-confidence investigational compound.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What DSIP is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Not a proven sleep compound &mdash; the original &ldquo;delta sleep-inducing&rdquo; claim has not held up reliably in human studies</li>
              <li>Not appropriate as a treatment for any diagnosed sleep disorder &mdash; insomnia and sleep apnea need evidence-based approaches first</li>
              <li>Not a compound with active research momentum &mdash; this is 1977 science that peaked in the 1980s and largely stalled</li>
              <li>Not characterizable as safe for long-term use &mdash; no long-term human data exists at all</li>
              <li>Not equivalent to Selank or melatonin for anxiety or sleep &mdash; both have more consistent human evidence</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>The HPA axis normalization angle &mdash; modulating ACTH and cortisol responses &mdash; has more consistent support than the sleep induction claim</li>
              <li>The opioid withdrawal data is the best-controlled human evidence and suggests real biological activity</li>
              <li>It is a small, simple 9-amino-acid peptide &mdash; easier to synthesize reliably than large complex proteins</li>
              <li>Mechanistically distinct from sedatives, melatonin, or magnesium &mdash; potentially a different angle on the stress-sleep interface</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
